Related Experiment Video
Updated: Jun 6, 2026
Acute Myocardial Infarction in Rats
Published on: February 16, 2011
[Initial observation of oxygen carriers with acute myocardial infarction in rats]
Xiangfang Zhao1, Xuelong Jin, Yuxin Wang
1Department of Physiology, Tianjin Medical University, Tianjin 300070, China.
Insights
Oxygen carriers show potential in reducing myocardial injury following acute myocardial infarction in rats. This study suggests they may offer a novel treatment by increasing oxygen supply to the heart muscle.
Area of Science:
- Cardiovascular Research
- Biomedical Engineering
- Ischemic Heart Disease
Context:
- Acute myocardial infarction (MI) remains a leading cause of mortality worldwide.
- Tissue hypoxia and subsequent injury are key pathological features of MI.
- Effective therapeutic strategies to mitigate myocardial damage are critically needed.
Purpose:
- To investigate the efficacy of oxygen carriers in reducing myocardial tissue injury in a rat model of acute myocardial infarction.
- To evaluate the impact of oxygen carriers on cardiac troponin T levels, myocardial infarction size, and histological signs of myocardial cell injury.
Summary:
- Rats underwent induced myocardial infarction or sham operation, followed by administration of oxygen carriers or vehicle.
- Cardiac troponin T levels, myocardial infarction size (MIS), and myocardial histology (hematoxylin-eosin staining) were assessed.
- While not statistically significant for cTnT, oxygen carriers significantly reduced MIS and improved myocardial histology compared to the model group, suggesting reduced injury.
Impact:
- Oxygen carriers demonstrated a trend towards reducing cardiac biomarkers and significantly reduced infarct size and histological damage.
- These findings suggest that oxygen carriers enhance oxygen supply to ischemic myocardium, mitigating injury.
- Oxygen carriers represent a promising novel therapeutic approach for treating myocardial infarction.
Abstract:
The purpose of this study was to test whether oxygen carriers could decrease tissue injury in a rat model of acute myocardial infarct. The study included 3 groups: SD rats in group II and group III were subjected to permanent occlusion of their left anterior descending coronary arteries; SD rats in group I were subjected to sham-operation. The success of modeling was assartained by ECG. Then the rats were given drug via caudal veins for 2 days. A quantitative evaluation was made with an automatic device for interpretation of cardiac troponin T (cTnT); heart staining was made for the calculation of myocardial infarction size (MIS); and myocardial tissue was taken and subjected to routine pathological hematoxylin-eosin (HE) staining for showing myocardial cell injury. cTnT in the sham-operation group was significantly lower by comparison with that in the model group (P < 0.01), and it was slightly lower in the oxygen carriers group than that in the model group, but there was no statistically significant difference (P = 0.18); MIS was significantly smaller in the sham-operation group than that in the model group (P < 0.01), and it was greater in the model rats than that in the oxygen carriers rats (P < 0.05). HE staining of myocardicum in the oxygen carriers group was significantly better than that in the model group (P < 0.01). The evidence suggested that oxygen carriers increased oxygen supply to ischemic myocardium, reduced the myocardial injury, and thus might offer a novel treatment of myocardial infarction.
